Versant Ventures Voyageurs
Canada-focused fund investing alongside Versant Ventures’ primary biotech funds and targeting seed, de novo and early-stage Canadian biotechnology companies
Stade d'investissement: Early
Northern Biologics
Northern Biologics’ mission is to develop first-in-class antibody therapeutics for oncology
First Ascent Ventures
Fund dedicated to enterprise applications investing primarily in emerging Canadian technology companies
Genesys Capital
Toronto-based early stage life sciences fund focused on building companies in the high-growth sectors of healthcare and biotechnology
Golden Ventures
Seed-stage, sector agnostic fund based in Toronto which invests in category-defining companies across North America
Idinvest Partners
Pan-European fund targeting Series A/Series B investments in sectors such as fintech, digital health, gaming, e-commerce, cybersecurity, IoT, artificial intelligence, VR/AR, blockchain and mobility
Information Venture Partners
Early stage fund investing in the emerging fintech sector and related enterprise software
Inovia
Fund specializing in early-stage information technology, supporting advanced-stage technology companies in sectors such as software, financial services, and healthcare
McRock Capital
World’s first dedicated fund in the industrial internet of things with a large and active network of strategic relationships
Real Ventures
Canada’s largest seed venture fund investing across a variety of sectors in the broader IT category, opportunistically favoring certain trends in the industry, such as artificial intelligence, Edtech and Fintech